Any current/future new fundraising through debt or equity?

UPL Limited has announced a rights issue of up to USD 500 million to augment cash flows. The company is also exploring capital raise options in its platforms. Proceeds from these initiatives will be used to repay debt. The board has approved the rights issue of up to USD 500 million, expected to be announced by the end of February 2024. The company aims to reduce net debt from approximately USD 3.7 billion (Dec 2023) to around USD 2.5 billion through operating cash flow and capital raises. Additional expected debt reduction of USD 400-500 million is anticipated post-rights issue.

Future growth expectations in sales/revenue/volumes?

Farm gate demand remains strong or above last year levels in most markets with positive grower margins, supporting yield and efficiency improvements. Anticipated market balancing as distributor destocking subsides by mid-calendar year 2024, especially in North America, Europe, and Brazil. Expectation of sequential margin improvement and recovery in sales volumes starting FY25, with Q4 FY24 seen as better than Q3. Growth momentum continues in differentiated and sustainable products, which now account for a larger portfolio share. Latin America (outside Brazil), Rest of World, China, Turkey, and

Future growth expectations in earnings/operating earnings/profits/EPS?

UPL expects gradual recovery starting FY 2025, driven by stabilization in grower and distribution demand as destocking eases (Page 7, Mike Frank). Contribution margins are anticipated to return to prior levels as high-cost inventory and excess rebates normalize (Pages 9, Mike Frank). Sustainable SG&A savings of $100 million targeted by FY 2025 versus FY 2023 will support improved profitability (Page 9, Mike Frank). Channel inventory normalization expected by mid-calendar year 2024, which should improve volumes and margins going forward (Page 6). Despite short-term challenges with price

UPLQ3 FY24Fertilizers & Agrochemicals

UPL Q3 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹517P/E: 23.5Market Cap: ₹46.4K CrSector: Fertilizers & Agrochemicals

Management growth scorecard

Revenue

Category 4

Margin

Category 3

Fundraise

Yes

Order

N/A

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 4

Farm gate demand remains strong or above last year levels in most markets with positive grower margins, supporting yield and efficiency improvements.
Anticipated market balancing as distributor destocking subsides by mid-calendar year 2024, especially in North America, Europe, and Brazil.
Expectation of sequential margin improvement and recovery in sales volumes starting FY25, with Q4 FY24 seen as better than Q3.
Growth momentum continues in differentiated and sustainable products, which now account for a larger portfolio share.
Latin America (outside Brazil), Rest of World, China, Turkey, and India platforms performing well, driving volume growth.
New product launches in crops like corn, sugarcane, and paddy expected to boost sales in next 2-3 quarters.
Slightly above current plant capacity utilization forecast for FY25, indicative of volume growth.
Industry-wide destocking pressures alleviating, with pricing now stabilizing post-patent active ingredients since Q2.

Margin guidance

Category 3

UPL expects gradual recovery starting FY 2025, driven by stabilization in grower and distribution demand as destocking eases (Page 7, Mike Frank).
Contribution margins are anticipated to return to prior levels as high-cost inventory and excess rebates normalize (Pages 9, Mike Frank).
Sustainable SG&A savings of $100 million targeted by FY 2025 versus FY 2023 will support improved profitability (Page 9, Mike Frank).
Channel inventory normalization expected by mid-calendar year 2024, which should improve volumes and margins going forward (Page 6).
Despite short-term challenges with price pressures and currency issues, operating margins and EBITDA are expected to improve sequentially in Q4 FY 2024 and beyond (Pages 5-7).
Mid- to long-term EBITDA margins could potentially return to historical ~20% levels, as UPL remains cost competitive with China and benefits from operational efficiencies (Page 9, Rajendra Darak and Mike Frank).
Investor Day planned in May 2024 will provide clearer guidance on mid- to long-term growth and margin trajectory (Page 9).

See what UPL management said on margin guidance — free account, 30 seconds.

Fundraise plans

Yes

UPL Limited has announced a rights issue of up to USD 500 million to augment cash flows.
The company is also exploring capital raise options in its platforms.
Proceeds from these initiatives will be used to repay debt.
The board has approved the rights issue of up to USD 500 million, expected to be announced by the end of February 2024.
The company aims to reduce net debt from approximately USD 3.7 billion (Dec 2023) to around USD 2.5 billion through operating cash flow and capital raises.
Additional expected debt reduction of USD 400-500 million is anticipated post-rights issue.

Order book

The transcript from the UPL Limited Q3 FY 2024 Results Conference Call does not explicitly mention specific figures or detailed information on the current or expected order book or pending orders. However, some related points inferred are: - The global crop protection market is experiencing prolonged destocking and elevated pricing pressures. - Distributors in major markets like North America, Brazil, and Europe are destocking or delaying purchases, impacting volume growth. - Volumes are down mid-single digit year-to-date with expectations of slightly improved volume in Q4 FY24, but still down low single digits compared to last year. - The expectation is that destocking will subside by mid-calendar year 2024 with a more balanced market as distributors begin to restock. - The company is building new plants for FY25 anticipating volume growth and market share gains. - No direct commentary on order book or pending orders, suggesting the focus is currently on managing inventory and working capital during market destocking.

See what UPL management said on order book — free account, 30 seconds.

Capex plans

Yes

- UPL Limited has slowed down on capital expenditure (capex) for the current fiscal year. - For the first nine months, capex spend was $190 million. - The company expects full-year capex to likely close at $250 million. - This is a reduction from their typical annual capex range of INR 3,000 to INR 3,500 crores (approximately $360-$420 million). - The slowdown indicates deferring or postponing larger projects planned earlier, likely as a measure to conserve cash amid challenging market conditions. - No specific details on new strategic investments or future large projects beyond this moderated capex spend were provided. (Source: Page 16)

Track UPL — get its next earnings analysis in your feed

How does UPL rank vs peers in Fertilizers & Agrochemicals?

Pro feature

ThisUPL

Rev 4Mar 3

See where UPL sits in Fertilizers & AgrochemicalsSee which companies these are, and every other name in the sector.Open rankings

How does UPL rank in Fertilizers & Agrochemicals?

Compare UPL against every Fertilizers & Agrochemicals company (Q3 FY24) on revenue, margins and earnings-call signals.

View Fertilizers & Agrochemicals leaderboard →

What UPL's management said in earlier quarters

Others in Fertilizers & Agrochemicals this season

Advance Agrolife Ltd (Q4 FY26)
Q4 FY26 total revenue: ₹1,259.07 million, up 40% YoY (Page 24). Key concall takeaways from Advance Agrolife Ltd's Q4 FY26 earnings call — and how it ranks…
Advance Agrolife Ltd (Q1 FY27)
Q1 FY27 revenue from operations: ₹3,304 million, a 96% year-on-year (YoY) increase (Page 23, 25, 22). Key concall takeaways from Advance Agrolife Ltd's Q1 FY27…
Bhagiradha Chemicals & Industries Ltd (Q4 FY26)
158.1 crores . Key concall takeaways from Bhagiradha Chemicals & Industries Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.
Bhagiradha Chemicals & Industries Ltd (Q1 FY27)
195.0 crore . Key concall takeaways from Bhagiradha Chemicals & Industries Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.

Compare:vs Coromandel International Ltd vs Fertilizers & Chemicals Travancore Ltd vs P I Industries

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →